President Donald Trump announced on Thursday that his administration will have a coronavirus vaccine ready for Americans before the year ends. The lofty promise came during his acceptance speech on the final night of the Republican National Convention. “In recent months, our nation and the entire planet has been struck by a new and powerful invisible enemy,” Trump said to a largely mask-less crowd of 1,500 supporters gathered on the White House lawn. “We are delivering lifesaving therapies. And we’ll produce a vaccine before the end of the year, or maybe even sooner.” The pledge is ambitious by any measure. Several companies are vying for vaccine approval from the U.S. Food and Drug Administration by the end of this year or by early 2021, but approval is just the beginning, The New York Times reported. Patients must be willing to take the vaccine, and there must be enough doses produced to be distributed widely. Medical experts noted that the audience setting for Trump’s speech posed the danger of community spread and set another bad example when Americans are being told they need to continue to wear masks, maintain social distancing and limit large gatherings, the Washington Post reported. “When you look at the way the president has handled the pandemic, it has basically been one evasion after another evasion,” Amesh Adalja, an infectious disease expert…  read on >

The first rapid coronavirus test that doesn’t need any special computer equipment to produce results was approved by the U.S. Food and Drug Administration on Wednesday. Made by Abbott Laboratories, the 15-minute test will sell for $5, giving it an edge over similar tests that need to be popped into a small machine, the Associated Press reported. No larger than a credit card, the Abbott test is based on the same technology used to test for the flu, strep throat and other infections. BinaxNOW is the fourth rapid test in the United States that detects COVID-19 antigens, proteins found on the surface of the coronavirus, rather than the virus itself, the AP reported. It’s considered a faster, but less precise, screening method. Abbott’s entry into the rapid COVID-19 test market offers yet another option to expand testing, the AP reported. The FDA also recently gave its blessing to a saliva test from Yale University that bypasses some of the supplies that have led to testing bottlenecks, the wire service said. Neither test can be performed at home. But several companies are developing rapid at-home tests, though none have yet won FDA approval, the AP reported. Abbott’s new test still requires a nasal swab be taken by a health worker, like most older coronavirus tests. The Yale saliva test eliminates the need for a swab, but…  read on >

Middle-aged men who were anxious or depressed teens are at increased risk for heart attack, according to a large, long-term study. It included more than 238,000 men born between 1952 and 1956 who underwent extensive exams when they were 18 or 19 years old and were followed to age 58. Men diagnosed with anxiety or depression in their late teens had a 20% higher risk of heart attack than those who didn’t, the study showed. The findings only reflect an association. The link was partly, but not fully, explained by poorer ability to cope with everyday stress and lower physical fitness in teens with the mental health conditions, according to findings presented Wednesday at a virtual meeting of the European Society of Cardiology. The takeaway: “Be vigilant and look for signs of stress, depression or anxiety that is beyond the normal teenage angst: Seek help if there seems to be a persistent problem,” suggested study author Cecilia Bergh, a senior lecturer in health sciences at Orebro University in Sweden. “If a healthy lifestyle is encouraged as early as possible in childhood and adolescence it is more likely to persist into adulthood and improve long-term health,” she said in a meeting news release. Bergh said researchers already knew that men who were physically fit but stressed as teens seemed less likely to maintain fitness. “Our previous…  read on >

Just weeks after colleges across the United States reopened their campuses for the fall semester, thousands of coronavirus infections are cropping up in students and staff alike. More than 1,500 American colleges and universities were tallied in The New York Times survey. That included every four-year public institution, every private college that competes in NCAA sports and others that identified cases. The case total: At least 26,000 cases and 64 deaths have been reported since the pandemic began, the Times reported. The trend is unfolding everywhere. The University of North Carolina at Chapel Hill sent most undergraduates home after COVID-19 clusters popped up in campus housing. In-person classes were delayed at Notre Dame as students tested positive by the hundreds. Clemson, Baylor, Louisville and dozens of other Division I universities have confirmed COVID-19 cases in their athletic departments. Meanwhile, aggressive testing of students moving into dorms turned up scores of cases at Iowa State, the Times reported. Meanwhile, the potential of convalescent plasma as a treatment for severe COVID-19 was still unclear Tuesday, as the World Health Organization cautioned the therapy remains experimental and American scientists challenged a key statistic cited by U.S. officials as grounds for emergency approval of the treatment. In announcing the approval this week, President Donald Trump and two of his top health officials stirred controversy when they used the same…  read on >